CL2011000713A1 - Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos. - Google Patents

Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.

Info

Publication number
CL2011000713A1
CL2011000713A1 CL2011000713A CL2011000713A CL2011000713A1 CL 2011000713 A1 CL2011000713 A1 CL 2011000713A1 CL 2011000713 A CL2011000713 A CL 2011000713A CL 2011000713 A CL2011000713 A CL 2011000713A CL 2011000713 A1 CL2011000713 A1 CL 2011000713A1
Authority
CL
Chile
Prior art keywords
imidacloprid
pharmaceutical composition
subtoxic
systematic control
oral
Prior art date
Application number
CL2011000713A
Other languages
English (en)
Inventor
Roland H Johnson
Douglas I Hepler
Kathleen G Palma
Wilians R Campbell
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of CL2011000713A1 publication Critical patent/CL2011000713A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica de un antiparasitario de imidacloprid para el tratamiento de pulgas en mamíferos.
CL2011000713A 2008-10-03 2011-03-31 Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos. CL2011000713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10277408P 2008-10-03 2008-10-03

Publications (1)

Publication Number Publication Date
CL2011000713A1 true CL2011000713A1 (es) 2011-08-26

Family

ID=42073871

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000713A CL2011000713A1 (es) 2008-10-03 2011-03-31 Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.

Country Status (28)

Country Link
US (2) US9820977B2 (es)
EP (1) EP2349265B1 (es)
JP (3) JP6110065B2 (es)
KR (3) KR101787917B1 (es)
CN (2) CN107041887A (es)
AU (1) AU2009298541B2 (es)
BR (1) BRPI0920434B1 (es)
CA (1) CA2736263C (es)
CL (1) CL2011000713A1 (es)
CO (1) CO6361913A2 (es)
DK (1) DK2349265T3 (es)
EC (1) ECSP11011023A (es)
ES (1) ES2588152T3 (es)
HR (1) HRP20161082T1 (es)
HU (1) HUE030412T2 (es)
IL (1) IL211624B (es)
MX (1) MX2011003415A (es)
NI (1) NI201100067A (es)
NZ (1) NZ592010A (es)
PE (1) PE20110395A1 (es)
PL (1) PL2349265T3 (es)
PT (1) PT2349265T (es)
RU (1) RU2526169C2 (es)
SI (1) SI2349265T1 (es)
SV (1) SV2011003871A (es)
UA (1) UA102565C2 (es)
WO (1) WO2010039892A1 (es)
ZA (1) ZA201102077B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133762A1 (en) * 2010-04-22 2011-10-27 Genesis Laboratories, Inc. Compositions and methods for control of sand flies and other blood sucking insects
US20120321703A1 (en) * 2011-06-16 2012-12-20 Daniel Kouri Capsule for oral pet medicine
CA2868381C (en) 2012-04-04 2020-07-07 Intervet International B.V. Soft chewable pharmaceutical products
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
PL3298027T3 (pl) 2015-05-20 2021-11-08 Boehringer Ingelheim Animal Health USA Inc. Przeciwrobacze związki depsipeptydów
CN108712900A (zh) 2015-12-19 2018-10-26 第时间美国泛型药物有限公司 软咀嚼片剂药物制剂
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
KR20190091268A (ko) * 2016-10-31 2019-08-05 더 스크립스 리서치 인스티튜트 매개체 전파 질환의 전염을 예방하기 위한 방법 및 조성물
US11382949B2 (en) 2016-11-16 2022-07-12 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
US20220048903A1 (en) 2018-07-09 2022-02-17 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic Heterocyclic Compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CN113825543A (zh) 2019-03-19 2021-12-21 勃林格殷格翰动物保健美国公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
KR102659363B1 (ko) 2020-05-26 2024-04-22 주식회사 경보제약 동물에서의 기생충 감염 질환을 치료 또는 예방하기 위한 수의학적 구강붕해필름 제제
PE20231205A1 (es) 2020-05-29 2023-08-17 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419814A1 (de) * 1994-06-07 1995-12-14 Bayer Ag Endoparasitizide
JP4538863B2 (ja) * 1998-06-08 2010-09-08 住友化学株式会社 寄生虫の駆除方法
US6140350A (en) 1998-06-08 2000-10-31 Sumitomo Chemical Company, Limited Method for controlling ectoparasites
JP2000062271A (ja) 1998-08-17 2000-02-29 Murata Mach Ltd 記録装置
NZ516790A (en) 1999-08-12 2003-03-28 Lilly Co Eli Oral treatment of companion animals with ectoparasiticidal spinosyns
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
JP4972843B2 (ja) 2000-11-09 2012-07-11 住友化学株式会社 動物外部寄生虫防除用経皮投与剤
CN1386420A (zh) 2001-05-22 2002-12-25 王玉万 一种含吡虫啉的宠物用抗寄生虫药
UA80096C2 (en) 2001-07-05 2007-08-27 Mikkel Sa Fencing for preventing insects to enter
CA2471043C (en) 2001-12-21 2012-06-19 Rhodia Inc. Stable surfactant compositions for suspending components
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
BR0318319A (pt) 2003-05-25 2006-07-18 Yuwan Wang métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
WO2006050772A1 (en) 2004-11-11 2006-05-18 Merial Ltd. Vinylaminopyrazole derivatives as pesticides
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
EP1838693B1 (en) 2005-01-21 2011-11-16 Merial Ltd. Pyrazole derivatives as pesticides
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds

Also Published As

Publication number Publication date
CN107041887A (zh) 2017-08-15
IL211624B (en) 2018-01-31
AU2009298541B2 (en) 2015-03-26
EP2349265A1 (en) 2011-08-03
CA2736263C (en) 2020-01-14
EP2349265A4 (en) 2012-10-24
WO2010039892A8 (en) 2011-03-24
BRPI0920434A2 (pt) 2015-12-22
NZ592010A (en) 2012-07-27
IL211624A0 (en) 2011-05-31
KR101787917B1 (ko) 2017-10-18
DK2349265T3 (en) 2016-09-05
RU2526169C2 (ru) 2014-08-20
WO2010039892A1 (en) 2010-04-08
KR20110067048A (ko) 2011-06-20
KR20170118235A (ko) 2017-10-24
US20180078537A1 (en) 2018-03-22
JP6110065B2 (ja) 2017-04-05
JP2016179983A (ja) 2016-10-13
SI2349265T1 (sl) 2016-10-28
US20100087492A1 (en) 2010-04-08
JP6388890B2 (ja) 2018-09-12
PL2349265T3 (pl) 2017-01-31
KR101903313B1 (ko) 2018-10-01
RU2011117203A (ru) 2012-11-10
EP2349265B1 (en) 2016-05-25
NI201100067A (es) 2012-03-15
AU2009298541A1 (en) 2010-04-08
ECSP11011023A (es) 2011-06-30
PE20110395A1 (es) 2011-06-19
HRP20161082T1 (hr) 2016-10-21
KR20160011711A (ko) 2016-02-01
BRPI0920434B1 (pt) 2021-07-27
MX2011003415A (es) 2011-08-12
ZA201102077B (en) 2012-12-27
JP2018127468A (ja) 2018-08-16
CN102170880A (zh) 2011-08-31
SV2011003871A (es) 2011-08-22
HUE030412T2 (hu) 2017-05-29
US9820977B2 (en) 2017-11-21
CA2736263A1 (en) 2010-04-08
ES2588152T3 (es) 2016-10-31
UA102565C2 (ru) 2013-07-25
CO6361913A2 (es) 2012-01-20
JP2012504636A (ja) 2012-02-23
PT2349265T (pt) 2016-08-31

Similar Documents

Publication Publication Date Title
CL2011000713A1 (es) Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
BRPI1012892A2 (pt) composto, e, composição farmacêutica.
ATE528989T1 (de) Kristalline feste rasagilin-base
BRPI0810936A2 (pt) Composto, composição para controlar uma praga de invertebrados e método para proteger um animal de uma praga parasítica deinvertebrados
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
CL2007003341A1 (es) Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras.
ECSP11011054A (es) Péptidos antivirales terapéuticos
CR11264A (es) Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
ECSP12011585A (es) Compuestos y composiciones para eltratamiento de enfermedades parasitarias
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
CL2015000462A1 (es) Composición fungicida y método para el control de las enfermedades de las plantas.
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
CO6741223A2 (es) Derivados de azetidina útiles para el tratamiento de enfermedades metabólicas e inflamatorias
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
UY36920A (es) Formulaciones de aminoácidos de liberación modificada administradas por vía oral
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BR112012002609A2 (pt) composição antimicrobiana sinergística.